ArticleTheranostics2025

Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease.

Rebiguli Aji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.